In search of novel targets associated with expression of PTEN, a gene that is frequently mutated in advanced PCa, DNA microarray profiling identified SEMA3C among the top three most differentially expressed genes between PTEN+ vs. PTEN−/− cancer cells (Peacock et al, 2009). This evidence concerns the gene SEMA3C and cancer.